Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.040 | 17 | 7618597 | intron variant | G/T | snv | 0.17 |
|
0.800 | 1.000 | 1 | 2011 | 2011 | ||||||||
|
1.000 | 0.040 | 17 | 7618597 | intron variant | G/T | snv | 0.17 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 17 | 7618597 | intron variant | G/T | snv | 0.17 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
1.000 | 0.040 | 17 | 7618597 | intron variant | G/T | snv | 0.17 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 17 | 7618597 | intron variant | G/T | snv | 0.17 |
|
0.700 | 1.000 | 1 | 2012 | 2012 | ||||||||
|
17 | 7628647 | intron variant | T/C | snv | 0.46 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
17 | 7628647 | intron variant | T/C | snv | 0.46 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
17 | 7629707 | intron variant | G/A | snv | 0.53 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
17 | 7629707 | intron variant | G/A | snv | 0.53 |
|
0.700 | 1.000 | 1 | 2016 | 2016 | ||||||||||
|
1.000 | 0.040 | 17 | 7629896 | intron variant | G/A | snv | 7.8E-02 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.030 | 0.667 | 3 | 2010 | 2014 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2013 | 2015 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Cardiovascular Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases | 0.010 | < 0.001 | 1 | 2011 | 2011 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2012 | 2012 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Endocrine System Diseases | 0.010 | 1.000 | 1 | 2019 | 2019 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Neoplasms; Male Urogenital Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 | |||||||
|
0.763 | 0.280 | 17 | 7630105 | 5 prime UTR variant | G/A | snv | 0.18 |
|
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases | 0.010 | < 0.001 | 1 | 2014 | 2014 | |||||||
|
0.827 | 0.200 | 17 | 7630399 | 3 prime UTR variant | T/C | snv | 9.4E-02 | 8.1E-02 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases | 0.010 | < 0.001 | 1 | 2012 | 2012 | ||||||
|
0.827 | 0.200 | 17 | 7630399 | 3 prime UTR variant | T/C | snv | 9.4E-02 | 8.1E-02 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||||
|
0.827 | 0.200 | 17 | 7630399 | 3 prime UTR variant | T/C | snv | 9.4E-02 | 8.1E-02 |
|
Nutritional and Metabolic Diseases | 0.010 | 1.000 | 1 | 2013 | 2013 | ||||||
|
0.827 | 0.200 | 17 | 7630399 | 3 prime UTR variant | T/C | snv | 9.4E-02 | 8.1E-02 |
|
Nutritional and Metabolic Diseases; Endocrine System Diseases | 0.010 | 1.000 | 1 | 2009 | 2009 |